
Quality of Synthetic Peptide Drugs: Key Influencing Factors and Control Measures
2026-05-27
Quality of Synthetic Peptide Drugs: Key Influencing Factors and Control Measures
Peptide drugs are widely used in clinical treatment, and consistent quality and controllable safety are central to their industrial production. The quality of synthetic peptide...
View More

Solid-Phase Synthesis of Antidiabetic Peptide Drugs: Recent Advances in Related Substances Research
2026-05-27
Solid-Phase Synthesis of Antidiabetic Peptide Drugs: Recent Advances in Related Substances Research
With the number of people with diabetes continuing to rise, antidiabetic peptide drugs have become a global focus of new drug R&D due to their advantages, in...
View More

Research Progress and Translational Prospects of Peptide-Composite Biomaterials in Promoting Peripheral Nerve Injury Repair
2026-05-08
Peripheral nerve injury, caused by various factors such as trauma, surgery, and disease, often leads to sensory abnormalities, muscle weakness, and even permanent loss of motor function, representing a prevalent and challenging clinical condition. Autologous...
View More

Overcoming Proteolytic Instability in a β-Turn Antimicrobial Peptide via Cyclization and Stereochemical Inversion to Combat MDR Bacteria
2026-04-21
Today, we are sharing an important study published in the Journal of Medicinal Chemistry, titled "Overcoming Proteolytic Instability in a β-Turn Antimicrobial Peptide via Cyclization and Stereochemical Inversion to Combat MDR Bacteria." Led by the team ...
View More

Interaction of Polypeptides with Hair Under Different Reducing Environments
2026-04-20
Modern hair care product development increasingly relies on bioactive ingredients, particularly peptides and proteins, aiming to repair hair damaged by chemical treatments (such as bleaching and dyeing) at the molecular level. However, the efficacy of thes...
View More

Advances and Challenges in Peptide Vaccines
2026-04-10
Peptide vaccines have emerged as a promising platform for the prevention and treatment of infectious diseases and cancer due to their safety, manufacturability, and antigen specificity. However, their intrinsic low immunogenicity and limited efficacy in late...
View More
Application of Pasireotide in the Personalized Treatment of Acromegaly
2026-04-10
Acromegaly is a chronic disease, the core feature of which is the excessive secretion of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Over 95% of cases are caused by pituitary somatotroph adenomas. Due to the high heterogeneity of these tu...
View More

Glycomacropeptide (GMP): A Sustainable Bioactive Peptide for Atopic Dermatitis Management and Skin Anti-Aging
2026-04-03
Atopic dermatitis (AD) is a highly prevalent chronic inflammatory skin disease globally, affecting 15%–30% of children and 2%–10% of adults. In the US alone, associated treatment costs exceed $5 billion annually. AD also significantly increases t...
View More


